Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Petter Bjornstad

Concepts (394)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Diabetic Nephropathies
76
2025
278
24.790
 Why?
Diabetes Mellitus, Type 2
67
2025
2429
10.900
 Why?
Diabetes Mellitus, Type 1
78
2025
3624
10.230
 Why?
Glomerular Filtration Rate
62
2025
681
8.620
 Why?
Kidney
50
2025
1302
6.430
 Why?
Uric Acid
23
2022
160
4.760
 Why?
Albuminuria
23
2024
181
4.300
 Why?
Insulin Resistance
20
2024
1164
4.270
 Why?
Renal Insufficiency, Chronic
19
2025
561
3.300
 Why?
Hemodynamics
23
2025
1081
2.910
 Why?
Pediatric Obesity
8
2023
570
2.880
 Why?
Metformin
12
2025
312
2.850
 Why?
Renal Insufficiency
6
2023
148
2.790
 Why?
Coronary Artery Disease
11
2022
678
2.590
 Why?
Biomarkers
36
2025
3880
2.510
 Why?
Diabetic Angiopathies
9
2019
262
2.480
 Why?
Glycopeptides
10
2021
44
2.300
 Why?
Bariatric Surgery
5
2020
192
2.270
 Why?
Obesity, Morbid
5
2020
238
2.200
 Why?
Vascular Calcification
6
2022
107
2.180
 Why?
Hypoglycemic Agents
20
2025
1212
2.130
 Why?
Adolescent
64
2025
20179
2.090
 Why?
Renin-Angiotensin System
10
2021
79
1.980
 Why?
Sodium-Glucose Transporter 2
12
2024
22
1.940
 Why?
Humans
167
2025
128417
1.800
 Why?
Sex Characteristics
6
2025
721
1.680
 Why?
Cardiovascular Diseases
15
2024
1999
1.670
 Why?
Creatinine
18
2025
475
1.650
 Why?
Young Adult
45
2025
12312
1.620
 Why?
Male
99
2025
62857
1.500
 Why?
Disease Progression
19
2024
2602
1.460
 Why?
Diabetic Ketoacidosis
3
2024
197
1.450
 Why?
Female
94
2025
68153
1.390
 Why?
Glucosides
9
2025
38
1.370
 Why?
Benzhydryl Compounds
9
2025
66
1.330
 Why?
Calcinosis
4
2015
230
1.330
 Why?
Obesity
12
2025
2858
1.290
 Why?
Adult
59
2025
35299
1.260
 Why?
Kidney Diseases
3
2023
367
1.210
 Why?
Diabetic Cardiomyopathies
4
2020
34
1.200
 Why?
Risk Factors
36
2024
9704
1.140
 Why?
Child
33
2025
20655
1.080
 Why?
Adiposity
5
2024
504
1.040
 Why?
Arterioles
3
2024
41
1.010
 Why?
Hypertension
9
2021
1235
1.010
 Why?
Follow-Up Studies
17
2025
4892
0.990
 Why?
Exercise Tolerance
3
2017
268
0.980
 Why?
Fructose
4
2021
106
0.970
 Why?
Atherosclerosis
4
2018
403
0.970
 Why?
Apolipoproteins B
2
2015
43
0.960
 Why?
Vascular Stiffness
7
2022
464
0.950
 Why?
Cross-Sectional Studies
19
2025
5039
0.940
 Why?
Body Composition
3
2025
644
0.940
 Why?
Uromodulin
3
2019
21
0.940
 Why?
Proteinuria
2
2024
88
0.940
 Why?
Hyperglycemia
5
2024
326
0.920
 Why?
Hyperuricemia
6
2021
44
0.920
 Why?
Middle Aged
50
2025
30889
0.910
 Why?
Vasopressins
3
2023
62
0.910
 Why?
Case-Control Studies
14
2025
3328
0.910
 Why?
Immunoglobulin Fc Fragments
1
2024
40
0.900
 Why?
Adiponectin
2
2016
234
0.900
 Why?
Glucagon-Like Peptides
1
2024
49
0.870
 Why?
Acute Kidney Injury
5
2024
773
0.870
 Why?
Hyperoxia
1
2024
87
0.830
 Why?
Prognosis
11
2025
3772
0.830
 Why?
Diabetic Retinopathy
4
2021
171
0.830
 Why?
Iothalamic Acid
1
2022
5
0.820
 Why?
Kidney Tubules
2
2021
114
0.820
 Why?
Dyslipidemias
5
2021
176
0.820
 Why?
Blood Glucose
11
2025
2093
0.810
 Why?
Cystatin C
8
2023
65
0.780
 Why?
Epithelial-Mesenchymal Transition
1
2024
199
0.780
 Why?
Kidney Glomerulus
5
2023
107
0.760
 Why?
Glucagon-Like Peptide-1 Receptor
6
2024
91
0.750
 Why?
Recombinant Fusion Proteins
1
2024
634
0.750
 Why?
Bone Density
1
2025
474
0.720
 Why?
Polycystic Kidney, Autosomal Dominant
1
2024
223
0.700
 Why?
Oxygen Consumption
3
2017
669
0.670
 Why?
Dried Blood Spot Testing
2
2018
91
0.670
 Why?
Kidney Failure, Chronic
4
2023
535
0.660
 Why?
Iohexol
2
2020
18
0.660
 Why?
Triglycerides
3
2022
523
0.650
 Why?
Oxygen
2
2024
899
0.650
 Why?
Blood Pressure
9
2022
1728
0.650
 Why?
Vascular Resistance
6
2020
367
0.640
 Why?
Longevity
6
2022
149
0.640
 Why?
Pilot Projects
7
2024
1563
0.630
 Why?
Cyclic GMP
1
2019
85
0.630
 Why?
Coronary Vessels
3
2017
236
0.620
 Why?
Lipid Metabolism Disorders
1
2018
2
0.620
 Why?
Cohort Studies
18
2025
5388
0.610
 Why?
Leptin
2
2017
218
0.600
 Why?
Weight Reduction Programs
1
2019
111
0.600
 Why?
Gastric Bypass
1
2020
107
0.600
 Why?
Overweight
3
2025
524
0.600
 Why?
Cardiotonic Agents
1
2018
124
0.590
 Why?
Hemofiltration
1
2018
22
0.590
 Why?
Sodium Bicarbonate
1
2018
37
0.580
 Why?
Cholesterol, HDL
2
2015
203
0.570
 Why?
Incidence
9
2021
2616
0.570
 Why?
Glucose
5
2023
982
0.560
 Why?
Ventricular Function, Left
3
2020
524
0.560
 Why?
Blood Vessels
1
2018
181
0.550
 Why?
Aorta
2
2019
404
0.540
 Why?
Up-Regulation
2
2016
825
0.520
 Why?
Nutrition Surveys
1
2017
261
0.510
 Why?
Cholesterol, LDL
2
2014
360
0.500
 Why?
Kidney Function Tests
4
2022
145
0.490
 Why?
Renal Circulation
3
2021
57
0.480
 Why?
Canada
7
2022
344
0.470
 Why?
Angiotensin II Type 2 Receptor Blockers
1
2014
7
0.460
 Why?
Aged
28
2025
21953
0.460
 Why?
Pregnancy Outcome
1
2017
389
0.460
 Why?
Body Mass Index
9
2025
2261
0.460
 Why?
Fasting
2
2025
264
0.450
 Why?
Hypoxia
2
2020
1036
0.450
 Why?
Echocardiography
2
2018
623
0.440
 Why?
Dietary Supplements
1
2018
531
0.440
 Why?
Goals
1
2015
160
0.430
 Why?
Drug Therapy, Combination
5
2025
1009
0.420
 Why?
Patient Care Planning
1
2014
149
0.420
 Why?
Vasoconstriction
3
2020
185
0.420
 Why?
Brain
1
2025
2620
0.410
 Why?
Heart Failure
3
2021
2145
0.410
 Why?
Lipids
2
2022
620
0.400
 Why?
Chitinase-3-Like Protein 1
2
2022
19
0.400
 Why?
Sodium
4
2023
205
0.390
 Why?
Contrast Media
1
2015
387
0.390
 Why?
Histidine
2
2022
58
0.390
 Why?
Age of Onset
2
2025
491
0.380
 Why?
Glucose Clamp Technique
5
2020
194
0.370
 Why?
Albumins
3
2022
101
0.360
 Why?
Clinical Trials as Topic
6
2022
993
0.360
 Why?
Angiotensin II
3
2020
93
0.360
 Why?
Guideline Adherence
1
2015
521
0.350
 Why?
Insulin
6
2024
2315
0.350
 Why?
Absorptiometry, Photon
2
2025
248
0.340
 Why?
Lipocalin-2
2
2022
76
0.340
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
413
0.330
 Why?
Prospective Studies
9
2025
7036
0.330
 Why?
Testosterone
3
2025
373
0.320
 Why?
Running
2
2023
227
0.310
 Why?
Pulse Wave Analysis
5
2022
248
0.300
 Why?
Diabetes Complications
2
2021
223
0.290
 Why?
Animals
15
2024
34479
0.280
 Why?
Metabolic Syndrome
3
2021
338
0.280
 Why?
Epidermal Growth Factor
2
2024
170
0.270
 Why?
Canagliflozin
3
2023
9
0.270
 Why?
Treatment Outcome
10
2019
10151
0.270
 Why?
Heat Stress Disorders
2
2018
69
0.260
 Why?
Dipeptidyl-Peptidase IV Inhibitors
3
2025
45
0.260
 Why?
Diabetes Mellitus
3
2021
999
0.260
 Why?
Age Factors
7
2019
3103
0.250
 Why?
Severity of Illness Index
3
2021
2721
0.250
 Why?
Time Factors
6
2018
6482
0.250
 Why?
Colorado
4
2017
4375
0.250
 Why?
Gliclazide
1
2025
2
0.250
 Why?
Linagliptin
1
2025
5
0.250
 Why?
Hydrogen-Ion Concentration
2
2018
536
0.250
 Why?
Leucine
2
2024
108
0.240
 Why?
Fatty Acid Binding Protein 3
1
2024
5
0.240
 Why?
Predictive Value of Tests
4
2018
1935
0.240
 Why?
Vascular Cell Adhesion Molecule-1
1
2024
37
0.230
 Why?
Early Diagnosis
2
2017
234
0.230
 Why?
Citric Acid Cycle
1
2024
50
0.230
 Why?
Estradiol
2
2025
486
0.230
 Why?
Gray Matter
1
2025
82
0.230
 Why?
Renin
2
2022
31
0.230
 Why?
Androgen Antagonists
1
2025
79
0.230
 Why?
Lipoproteins
2
2022
171
0.230
 Why?
Sex Factors
4
2025
1945
0.230
 Why?
Diuretics
2
2023
74
0.230
 Why?
Endothelin Receptor Antagonists
2
2024
61
0.220
 Why?
Mineralocorticoid Receptor Antagonists
2
2024
45
0.220
 Why?
National Institutes of Health (U.S.)
1
2024
122
0.210
 Why?
Receptors, Vasopressin
2
2021
19
0.210
 Why?
Magnetic Resonance Imaging
3
2025
3376
0.210
 Why?
Inappropriate ADH Syndrome
1
2023
8
0.210
 Why?
Cysts
1
2024
108
0.210
 Why?
Hyponatremia
1
2023
40
0.200
 Why?
Fluorocarbons
1
2024
109
0.200
 Why?
Longitudinal Studies
5
2024
2710
0.200
 Why?
Consensus
2
2022
613
0.200
 Why?
Malates
1
2022
5
0.200
 Why?
Fumarates
1
2022
9
0.200
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2023
115
0.200
 Why?
Threonine
1
2022
44
0.200
 Why?
Carboxylic Acids
1
2022
32
0.200
 Why?
Natriuresis
2
2019
11
0.190
 Why?
Diabetes Mellitus, Experimental
1
2023
173
0.190
 Why?
Rats
2
2024
5165
0.190
 Why?
Amino Acids
2
2024
474
0.190
 Why?
Phenylalanine
1
2022
65
0.190
 Why?
Pathology, Clinical
1
2022
36
0.190
 Why?
Chemokine CCL2
1
2022
118
0.190
 Why?
Arizona
1
2021
78
0.180
 Why?
Glycine
1
2022
164
0.180
 Why?
Glucagon-Like Peptide 1
1
2022
112
0.180
 Why?
Oxidation-Reduction
1
2024
1001
0.180
 Why?
Osmolar Concentration
2
2018
164
0.180
 Why?
p-Aminohippuric Acid
1
2020
6
0.180
 Why?
Tryptophan
1
2022
169
0.180
 Why?
Multivariate Analysis
2
2014
1484
0.170
 Why?
Interleukin-18
1
2022
236
0.170
 Why?
Japan
5
2017
96
0.170
 Why?
Nephrosis
1
2020
4
0.170
 Why?
Natriuretic Peptide, Brain
1
2021
99
0.170
 Why?
Furosemide
1
2020
38
0.170
 Why?
Asymptomatic Diseases
2
2019
84
0.170
 Why?
Calcium Channel Blockers
1
2021
123
0.170
 Why?
Transgender Persons
1
2023
170
0.170
 Why?
Diabetic Neuropathies
1
2021
90
0.170
 Why?
Angiotensin-Converting Enzyme Inhibitors
2
2024
199
0.170
 Why?
Sodium-Glucose Transporter 1
1
2019
10
0.170
 Why?
Body Water
1
2019
18
0.160
 Why?
Double-Blind Method
2
2025
1848
0.160
 Why?
Diabetic Foot
1
2019
26
0.160
 Why?
Models, Biological
3
2016
1691
0.160
 Why?
Glycolysis
1
2021
293
0.160
 Why?
Glomerulonephritis
1
2019
46
0.160
 Why?
Glycosides
1
2019
37
0.160
 Why?
Blood Chemical Analysis
1
2019
94
0.160
 Why?
Postmenopause
1
2021
348
0.160
 Why?
Endothelial Cells
1
2024
698
0.150
 Why?
beta 2-Microglobulin
1
2018
47
0.150
 Why?
Myocardial Contraction
1
2020
330
0.150
 Why?
Body Temperature Regulation
1
2019
95
0.150
 Why?
Energy Metabolism
1
2024
831
0.150
 Why?
Microscopy, Polarization
1
2018
31
0.150
 Why?
Carotid Intima-Media Thickness
1
2018
90
0.150
 Why?
Allopurinol
1
2018
60
0.150
 Why?
Hepatitis A Virus Cellular Receptor 1
1
2018
43
0.150
 Why?
Biopsy
1
2022
1081
0.150
 Why?
Weight Loss
2
2020
725
0.150
 Why?
Pharmaceutical Preparations
1
2020
168
0.150
 Why?
Obesity, Metabolically Benign
1
2017
4
0.140
 Why?
Prehypertension
1
2017
27
0.140
 Why?
Glucose Tolerance Test
2
2019
356
0.140
 Why?
Glomerulosclerosis, Focal Segmental
1
2017
42
0.140
 Why?
Life Style
1
2019
460
0.140
 Why?
Hyperthermia, Induced
1
2018
108
0.140
 Why?
Deamino Arginine Vasopressin
1
2016
11
0.140
 Why?
Urinary Calculi
1
2017
11
0.140
 Why?
Precision Medicine
1
2020
384
0.140
 Why?
Gastrointestinal Microbiome
1
2024
633
0.140
 Why?
Peptide Fragments
1
2021
684
0.130
 Why?
Ventricular Dysfunction, Left
1
2020
383
0.130
 Why?
Tomography, X-Ray Computed
2
2018
2523
0.130
 Why?
Disease Models, Animal
5
2021
3937
0.130
 Why?
Magnetic Resonance Angiography
1
2018
235
0.130
 Why?
Blood Banks
1
2016
40
0.130
 Why?
Morbidity
1
2017
301
0.130
 Why?
Dehydration
1
2016
50
0.130
 Why?
Cardiorespiratory Fitness
1
2017
49
0.130
 Why?
Regional Blood Flow
1
2018
459
0.130
 Why?
Anti-Inflammatory Agents
1
2020
468
0.130
 Why?
Vasodilation
1
2020
464
0.130
 Why?
Child, Preschool
3
2024
10384
0.130
 Why?
Mice
4
2023
16602
0.130
 Why?
Cognition
1
2024
1107
0.130
 Why?
Survival Rate
2
2017
1869
0.130
 Why?
Vitreoretinopathy, Proliferative
1
2016
12
0.130
 Why?
Logistic Models
3
2017
1974
0.130
 Why?
Linear Models
2
2017
813
0.130
 Why?
Hot Temperature
1
2018
358
0.120
 Why?
Heart Rate
1
2019
800
0.120
 Why?
Echocardiography, Doppler
1
2016
108
0.120
 Why?
Liver Diseases
1
2018
284
0.120
 Why?
Filtration
1
2015
65
0.120
 Why?
Risk Assessment
4
2019
3232
0.120
 Why?
Software
1
2019
608
0.120
 Why?
Apolipoproteins
1
2014
38
0.120
 Why?
Enzyme Inhibitors
1
2018
809
0.120
 Why?
Blood Pressure Determination
1
2015
148
0.110
 Why?
Purines
1
2015
169
0.110
 Why?
Phenotype
1
2022
3044
0.110
 Why?
Achievement
1
2014
57
0.110
 Why?
Stress, Mechanical
1
2016
463
0.110
 Why?
Immunity, Innate
1
2019
802
0.110
 Why?
Liver
2
2021
1826
0.110
 Why?
Randomized Controlled Trials as Topic
1
2019
1356
0.100
 Why?
Primary Prevention
1
2015
185
0.100
 Why?
Exercise Test
1
2016
613
0.100
 Why?
Research Design
1
2019
1036
0.100
 Why?
United States
3
2024
13830
0.100
 Why?
Biomechanical Phenomena
1
2016
778
0.100
 Why?
Adenosine Triphosphate
1
2015
471
0.100
 Why?
Cholesterol
1
2014
406
0.100
 Why?
Aged, 80 and over
3
2018
7033
0.100
 Why?
Antihypertensive Agents
1
2016
485
0.100
 Why?
RNA, Messenger
1
2019
2675
0.100
 Why?
Proof of Concept Study
2
2024
65
0.090
 Why?
Regression Analysis
1
2014
978
0.090
 Why?
Feasibility Studies
1
2015
860
0.090
 Why?
Ambulatory Care
1
2015
503
0.090
 Why?
Exercise
1
2022
1929
0.090
 Why?
Vascular Diseases
1
2013
232
0.090
 Why?
Societies, Medical
1
2015
745
0.090
 Why?
Hematocrit
2
2021
93
0.090
 Why?
Gene Expression Regulation
1
2019
2505
0.080
 Why?
Practice Guidelines as Topic
1
2017
1478
0.080
 Why?
Retrospective Studies
7
2024
14454
0.080
 Why?
Fructokinases
2
2021
31
0.080
 Why?
Registries
1
2016
1877
0.080
 Why?
Inflammation
2
2021
2654
0.070
 Why?
Prevalence
3
2019
2547
0.070
 Why?
Reproducibility of Results
1
2015
3020
0.070
 Why?
Fibrosis
2
2021
512
0.070
 Why?
Pregnancy
1
2017
6357
0.060
 Why?
Postprandial Period
1
2025
103
0.060
 Why?
Isoleucine
1
2024
14
0.060
 Why?
Mice, Inbred C57BL
3
2021
5272
0.060
 Why?
Valine
1
2024
74
0.050
 Why?
Obesity, Abdominal
1
2024
47
0.050
 Why?
Aging
1
2014
1750
0.050
 Why?
Multicenter Studies as Topic
1
2024
285
0.050
 Why?
RNA, Transfer
1
2024
130
0.050
 Why?
Bromocriptine
1
2022
28
0.050
 Why?
Infant, Newborn
1
2014
5687
0.050
 Why?
Environmental Pollutants
1
2024
142
0.050
 Why?
Benzbromarone
1
2022
1
0.050
 Why?
Aldosterone
1
2022
42
0.050
 Why?
Cytokines
2
2021
1983
0.050
 Why?
Glycoproteins
1
2024
337
0.050
 Why?
Controlled Clinical Trials as Topic
1
2021
27
0.050
 Why?
Adenine
1
2023
255
0.050
 Why?
Clinical Trials, Phase III as Topic
1
2021
90
0.050
 Why?
Inulin
1
2021
7
0.050
 Why?
Hep G2 Cells
1
2021
61
0.040
 Why?
Drinking
1
2021
40
0.040
 Why?
Serum Albumin
1
2021
145
0.040
 Why?
TOR Serine-Threonine Kinases
1
2023
380
0.040
 Why?
Uricosuric Agents
1
2020
2
0.040
 Why?
Diuretics, Osmotic
1
2020
1
0.040
 Why?
Infant
1
2014
8914
0.040
 Why?
Cross-Over Studies
1
2022
513
0.040
 Why?
Environmental Exposure
1
2024
461
0.040
 Why?
Mendelian Randomization Analysis
1
2020
50
0.040
 Why?
Cell Hypoxia
1
2021
229
0.040
 Why?
Diastole
1
2020
148
0.040
 Why?
Chemokines
1
2021
221
0.040
 Why?
Cytoprotection
1
2019
50
0.040
 Why?
Systole
1
2020
190
0.040
 Why?
Netherlands
1
2019
77
0.040
 Why?
Neuropsychological Tests
1
2024
1002
0.040
 Why?
Drug Interactions
1
2021
357
0.040
 Why?
Preoperative Period
1
2019
113
0.040
 Why?
Cognitive Dysfunction
1
2024
343
0.040
 Why?
Magnetic Resonance Imaging, Cine
1
2020
184
0.040
 Why?
Incretins
1
2018
18
0.040
 Why?
Macular Edema
1
2018
41
0.040
 Why?
Photography
1
2018
97
0.040
 Why?
Renal Elimination
1
2018
7
0.040
 Why?
Inflammation Mediators
1
2021
495
0.040
 Why?
Xanthine Oxidase
1
2018
77
0.040
 Why?
HSP70 Heat-Shock Proteins
1
2018
67
0.040
 Why?
Diet Therapy
1
2018
34
0.040
 Why?
Renal Dialysis
1
2021
417
0.040
 Why?
Anti-Obesity Agents
1
2018
53
0.040
 Why?
Cardiovascular System
1
2019
137
0.040
 Why?
Lipoproteins, LDL
1
2017
126
0.030
 Why?
Renal Plasma Flow, Effective
1
2016
1
0.030
 Why?
Tomography, Optical Coherence
1
2018
187
0.030
 Why?
Blood Urea Nitrogen
1
2016
53
0.030
 Why?
Blood Pressure Monitoring, Ambulatory
1
2017
84
0.030
 Why?
Water-Electrolyte Balance
1
2016
34
0.030
 Why?
Thiazolidinediones
1
2018
137
0.030
 Why?
Aldehyde Reductase
1
2016
27
0.030
 Why?
Interleukin-6
1
2021
716
0.030
 Why?
Infusions, Intravenous
1
2018
385
0.030
 Why?
Ammonia
1
2016
62
0.030
 Why?
Proportional Hazards Models
1
2019
1196
0.030
 Why?
Age Distribution
1
2017
371
0.030
 Why?
Sex Distribution
1
2017
358
0.030
 Why?
Collagen
1
2018
429
0.030
 Why?
Waist Circumference
1
2015
138
0.030
 Why?
Combined Modality Therapy
1
2018
1204
0.030
 Why?
Circadian Rhythm
1
2017
409
0.030
 Why?
Blood Glucose Self-Monitoring
1
2019
601
0.030
 Why?
Mice, Knockout
1
2021
2755
0.030
 Why?
Complement Activation
1
2016
365
0.030
 Why?
Exercise Therapy
1
2018
413
0.030
 Why?
Heart Ventricles
1
2018
765
0.030
 Why?
Peptides
1
2018
908
0.020
 Why?
Rats, Sprague-Dawley
1
2017
2239
0.020
 Why?
Gene-Environment Interaction
1
2014
185
0.020
 Why?
Comorbidity
1
2017
1543
0.020
 Why?
Models, Statistical
1
2015
621
0.020
 Why?
Databases, Factual
1
2017
1269
0.020
 Why?
Non-alcoholic Fatty Liver Disease
1
2014
258
0.020
 Why?
Algorithms
1
2015
1618
0.020
 Why?
Hospitalization
1
2017
2057
0.020
 Why?
Neoplasms
1
2014
2464
0.010
 Why?
Bjornstad's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (394) concept(s)
_
Co-Authors Expand Description
See all (66) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)